Data / Form D filings / Tempo Therapeutics, Inc.
Tempo Therapeutics, Inc.: Form D filings
Tempo Therapeutics, Inc., a biotechnology company in San Diego, CA, filed 4 Form D notices with the SEC between 2020 and 2026. The latest, on September 11, 2026, reports $14 million sold of a $14.5 million offering to 43 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3030 BUNKER HILL STREET Suite 308, San Diego, CA, 92109
- Phone
- (619) 202-7445
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1813688
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | New notice | $14,500,000 | $14,000,000 | $500,000 | 43 | Aug 27, 2026 | sec.gov |
| Mar 15, 2024 | New notice | $16,793,660 | $16,327,664 | $465,996 | 26 | Mar 1, 2024 | sec.gov |
| Aug 9, 2021 | Amendment | $3,898,500 | $3,844,046 | $54,454 | 39 | Jul 10, 2015 | sec.gov |
| Jun 2, 2020 | New notice | $3,898,500 | $3,844,046 | $54,454 | 39 | May 21, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Westbrook Weaver | Executive Officer, Director | |
| Donald Griffin | Director | |
| Biren Mehta | Director | |
| Steven Sands | Director | |
| Eric Richman | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 7, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tempo Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.